tetano
Editor, Senior Moderator
Infect Chemother
. 2022 Dec;54(4):774-780.
doi: 10.3947/ic.2022.0075.
SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers
Theresia Santi[SUP] 1 [/SUP], Lina Kamarga[SUP] 1 [/SUP], Baringin De Samakto[SUP] 1 [/SUP], Juandy Jo[SUP] 2 3 [/SUP]
Affiliations
Abstract
It remains unknown whether the Indonesian healthcare workers (HCWs) who had received two doses of CoronaVac vaccine and one dose of mRNA-1273 booster could be protected during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron wave. In total, 125 infection-naïve and 10 previously infected HCWs were recruited. The mRNA-1273 booster substantially increased titer of anti-SARS-CoV-2 spike protein receptor-binding domain antibodies. However, the monitoring revealed that 34 out of 125 infection-naïve (27.2%) and 3 out of 10 previously infected HCWs (30.0%) were infected during the Omicron wave. All infected HCWs were either asymptomatic or having mild coronavirus disease 2019 (COVID-19) and subsequently fully recovered, supporting the heterologous prime-boost strategy against COVID-19.
Keywords: Breakthrough infection; COVID-19 vaccines; Heterologous prime-boost; SARS-CoV-2 variant.
. 2022 Dec;54(4):774-780.
doi: 10.3947/ic.2022.0075.
SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers
Theresia Santi[SUP] 1 [/SUP], Lina Kamarga[SUP] 1 [/SUP], Baringin De Samakto[SUP] 1 [/SUP], Juandy Jo[SUP] 2 3 [/SUP]
Affiliations
- PMID: 36596685
- DOI: 10.3947/ic.2022.0075
Abstract
It remains unknown whether the Indonesian healthcare workers (HCWs) who had received two doses of CoronaVac vaccine and one dose of mRNA-1273 booster could be protected during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron wave. In total, 125 infection-naïve and 10 previously infected HCWs were recruited. The mRNA-1273 booster substantially increased titer of anti-SARS-CoV-2 spike protein receptor-binding domain antibodies. However, the monitoring revealed that 34 out of 125 infection-naïve (27.2%) and 3 out of 10 previously infected HCWs (30.0%) were infected during the Omicron wave. All infected HCWs were either asymptomatic or having mild coronavirus disease 2019 (COVID-19) and subsequently fully recovered, supporting the heterologous prime-boost strategy against COVID-19.
Keywords: Breakthrough infection; COVID-19 vaccines; Heterologous prime-boost; SARS-CoV-2 variant.